Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. (2021)
Attributed to:
A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41590-021-00902-8
PubMed Identifier: 33674800
Publication URI: http://europepmc.org/abstract/MED/33674800
Type: Journal Article/Review
Volume: 22
Parent Publication: Nature immunology
Issue: 5
ISSN: 1529-2908